Skip to main content
Top
Published in: Acta Diabetologica 2/2015

01-04-2015 | Original Article

Increased risk of severe diabetic ketoacidosis among Jewish ultra-orthodox children

Authors: Noah Gruber, Brian Reichman, Liat Lerner-Geva, Orit Pinhas-Hamiel

Published in: Acta Diabetologica | Issue 2/2015

Login to get access

Abstract

Aims

Diabetic ketoacidosis (DKA) at diabetes diagnosis is a dangerous yet potentially preventable condition. Young age, low socioeconomic status, and low parental education have been found to be associated with increased risk of DKA. We aimed to evaluate the impact of religious affiliation on presentation with DKA at type 1 diabetes mellitus (T1DM) diagnosis in Jewish children.

Methods

The study comprised an analysis of medical records of all consecutive patients with new-onset T1DM who were admitted to one tertiary medical center from January 2007 to January 2014. DKA was defined as venous pH <7.3 or HCO3  < 15 mmol/l, and severe DKA as pH <7.1 or HCO3  < 5 mmol/l.

Results

Of 81 patients with new-onset T1DM (38 females, mean ± SD age at diagnosis 9.9 ± 4.2 years), 34 (42 %) presented with DKA: 21 of 60 (35 %) of patients from secular families and 13 of 21 (62 %) from ultra-orthodox families. Children from ultra-orthodox families had a 3.5-fold increased risk of presenting with DKA than children from secular families (95 % CI 1.2–10.1, p = 0.02) and a 3.8-fold risk to be admitted with severe DKA (95 % CI 1.1–12.6, p = 0.02). Other factors that were found to be associated with an increased risk of DKA were younger age, an absence of maternal academic education, and residence in an area of low socioeconomic status.

Conclusions

DKA and severe DKA at diabetes diagnosis were more common among religious ultra-orthodox than among secular Jewish children. Awareness of the symptoms and dangers of DKA in new-onset T1DM should be directed to particularly high-risk population groups.
Literature
1.
go back to reference Patterson CC, Dahlquist GG, Gyürüs E et al (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 373:2027–2033. doi:10.1016/S0140-6736(09)60568-7 CrossRefPubMed Patterson CC, Dahlquist GG, Gyürüs E et al (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 373:2027–2033. doi:10.​1016/​S0140-6736(09)60568-7 CrossRefPubMed
3.
go back to reference Zhao Z, Sun C, Wang C et al (2014) Rapidly rising incidence of childhood type 1 diabetes in Chinese population: epidemiology in Shanghai during 1997–2011. Acta Diabetol. doi:10.1007/s00592-014-0590-2 Zhao Z, Sun C, Wang C et al (2014) Rapidly rising incidence of childhood type 1 diabetes in Chinese population: epidemiology in Shanghai during 1997–2011. Acta Diabetol. doi:10.​1007/​s00592-014-0590-2
6.
go back to reference Scibilia J, Finegold D, Dorman J et al (1986) Why do children with diabetes die? Acta Endocrinol Suppl (Copenh) 279:326–333 Scibilia J, Finegold D, Dorman J et al (1986) Why do children with diabetes die? Acta Endocrinol Suppl (Copenh) 279:326–333
8.
go back to reference Fernandez Castañer M, Montaña E, Camps I et al (1996) Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes. Diabetes Metab 22:349–355PubMed Fernandez Castañer M, Montaña E, Camps I et al (1996) Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes. Diabetes Metab 22:349–355PubMed
9.
go back to reference Mortensen HB1, Swift PG, Holl RW et al (2010) Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis. Pediatr Diabetes 11:218–226 Mortensen HB1, Swift PG, Holl RW et al (2010) Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis. Pediatr Diabetes 11:218–226
12.
go back to reference Cameron FJ, Scratch SE, Nadebaum C et al (2014) Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children. Diabetes Care 37:1554–1562. doi:10.2337/dc13-1904 CrossRefPubMed Cameron FJ, Scratch SE, Nadebaum C et al (2014) Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children. Diabetes Care 37:1554–1562. doi:10.​2337/​dc13-1904 CrossRefPubMed
13.
go back to reference Usher-Smith JA, Thompson MJ, Sharp SJ, Walter FM (2011) Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ 343:d4092CrossRefPubMedCentralPubMed Usher-Smith JA, Thompson MJ, Sharp SJ, Walter FM (2011) Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ 343:d4092CrossRefPubMedCentralPubMed
15.
go back to reference Lévy-Marchal C, Patterson CC, Green A (2001) Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. Diabetologia 44(Suppl 3):B75–B80CrossRefPubMed Lévy-Marchal C, Patterson CC, Green A (2001) Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. Diabetologia 44(Suppl 3):B75–B80CrossRefPubMed
16.
18.
go back to reference Uçar A, Saka N, Baş F et al (2013) Frequency and severity of ketoacidosis at onset of autoimmune type 1 diabetes over the past decade in children referred to a tertiary paediatric care centre: potential impact of a national programme highlighted. J Pediatr Endocrinol Metab 26:1059–1065. doi:10.1515/jpem-2013-0060 CrossRefPubMed Uçar A, Saka N, Baş F et al (2013) Frequency and severity of ketoacidosis at onset of autoimmune type 1 diabetes over the past decade in children referred to a tertiary paediatric care centre: potential impact of a national programme highlighted. J Pediatr Endocrinol Metab 26:1059–1065. doi:10.​1515/​jpem-2013-0060 CrossRefPubMed
20.
go back to reference Vanelli M, Chiari G, Ghizzoni L et al (1999) Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care 22:7–9CrossRefPubMed Vanelli M, Chiari G, Ghizzoni L et al (1999) Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care 22:7–9CrossRefPubMed
24.
25.
go back to reference The Diabetes Control and Complications Trial (DCCT) (1986) Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes 35:530–45 The Diabetes Control and Complications Trial (DCCT) (1986) Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes 35:530–45
26.
go back to reference Dunger DB, Sperling MA, Acerini CL et al (2004) ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 89:188–194CrossRefPubMedCentralPubMed Dunger DB, Sperling MA, Acerini CL et al (2004) ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 89:188–194CrossRefPubMedCentralPubMed
31.
go back to reference Hilmi A, Pasternak Y, Friger M et al (2013) Ethnic differences in glycemic control and diabetic ketoacidosis rate among children with diabetes mellitus type 1 in the Negev area. Isr Med Assoc J 15:267–270PubMed Hilmi A, Pasternak Y, Friger M et al (2013) Ethnic differences in glycemic control and diabetic ketoacidosis rate among children with diabetes mellitus type 1 in the Negev area. Isr Med Assoc J 15:267–270PubMed
32.
go back to reference Colagiuri S (The Boden Institute of Obesity N, and Exercise, University of Sydney A) (2011) The global IDF/ISPAD guideline for diabetes in children and adolescence Colagiuri S (The Boden Institute of Obesity N, and Exercise, University of Sydney A) (2011) The global IDF/ISPAD guideline for diabetes in children and adolescence
34.
go back to reference Lightman E (Faculty of Social Work, University of Toronto, 246 Bloor Street W., Toronto, Ontario M5S1A1, Canada) Shor R (Paul Baerwald School of Social Work, Hebrew University of Jerusalem, Mt. Scopus, 91905 I) (2002) Askanim: informal helpers and cultural brokers as a bridge to secular helpers for the ultra-orthodox Jewish communities of Israel and Canada. Fam Soc 83:315–324 Lightman E (Faculty of Social Work, University of Toronto, 246 Bloor Street W., Toronto, Ontario M5S1A1, Canada) Shor R (Paul Baerwald School of Social Work, Hebrew University of Jerusalem, Mt. Scopus, 91905 I) (2002) Askanim: informal helpers and cultural brokers as a bridge to secular helpers for the ultra-orthodox Jewish communities of Israel and Canada. Fam Soc 83:315–324
35.
38.
39.
go back to reference Komulainen J, Lounamaa R, Knip M et al (1996) Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood diabetes in Finland study group. Arch Dis Child 75:410–415CrossRefPubMedCentralPubMed Komulainen J, Lounamaa R, Knip M et al (1996) Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood diabetes in Finland study group. Arch Dis Child 75:410–415CrossRefPubMedCentralPubMed
40.
go back to reference Sadauskaite-Kuehne V, Samuelsson U, Jasinskiene E et al (2002) Severity at onset of childhood type 1 diabetes in countries with high and low incidence of the condition. Diabetes Res Clin Pract 55:247–254CrossRefPubMed Sadauskaite-Kuehne V, Samuelsson U, Jasinskiene E et al (2002) Severity at onset of childhood type 1 diabetes in countries with high and low incidence of the condition. Diabetes Res Clin Pract 55:247–254CrossRefPubMed
Metadata
Title
Increased risk of severe diabetic ketoacidosis among Jewish ultra-orthodox children
Authors
Noah Gruber
Brian Reichman
Liat Lerner-Geva
Orit Pinhas-Hamiel
Publication date
01-04-2015
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 2/2015
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-014-0653-4

Other articles of this Issue 2/2015

Acta Diabetologica 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.